ArticleScientific reports2025
Enhanced production and structural characterization of exopolysaccharide from Sporocarcina psychrophile MTCC 2908 through two step optimization for therapeutic evaluation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Process optimization and characterization of levan from Sporosarcina globispora MTCC 4776.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The production and extraction of Exopolysaccharide (EPS) from the bacterial strain Sporocarcina psychrophila (MTCC-2908) was carried out in submerged fermentation conditions, yielding 1.22 g/L in 48 h at unoptimized conditions. To enhance EPS yield, a two-stage optimization strategy was employed using Plackett-Burman design (PBD) for parameter screening, followed by central composite design (CCD) for optimization. To further enhance the yield of EPS. Ten fermentation parameters were initially screened via PB design, of which five (Glucose, NH
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.